Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.61 |
| ▸ | FYN | P06241 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
| ▸ | MTOR | P42345 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24761596 | 1.00 | CYP1A2 (0.61) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| SCHEMBL29881538 | 0.92 | KDM4E (0.64) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| SCHEMBL24761068 | 0.92 | KDM4E (0.64) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| Methyldopate SCHEMBL29587132 | 0.87 | HSD17B10 (0.66) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| Methyldopate SCHEMBL297359 | 0.87 | HSD17B10 (0.66) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| Methyldopate SCHEMBL11430187 | 0.87 | HSD17B10 (0.66) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| SCHEMBL11509446 | 0.87 | MAPT (0.52) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| SCHEMBL11850560 | 0.86 | KDM4E (0.61) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL11454988 | 0.86 | KDM4E (0.61) | CYP1A2CYP3A4KDM4EALDH1A1POLB | |
| SCHEMBL11447165 | 0.86 | KDM4E (0.61) | CYP1A2CYP3A4KDM4EALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230109489-A1 | Compound and Use Thereof | FELIQS CORPORATION (JP) | 2023-04-06 | — | — | US | disclosed |
| EP-4101839-A1 | COMPOUND AND USE THEREOF | Feliqs Corporation (JP) | 2022-12-14 | — | — | EP | disclosed |
| CN-115103832-A | Compound and use thereof | 株式会社费利克斯 | 2022-09-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230109489-A1 | Compound and Use Thereof | LPO, GPX4, ALOX15 | CYP1A2 1164/4885CYP3A4 222/4885KDM4E 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.